143 related articles for article (PubMed ID: 65189)
1. Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma.
Rodriguez V; Cabanillas F; Burgess MA; McKelvey EM; Valdivieso M; Bodey GP; Freireich EJ
Blood; 1977 Mar; 49(3):325-33. PubMed ID: 65189
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
Skarin AT; Rosenthal DS; Moloney WC; Frei E
Blood; 1977 May; 49(5):759-70. PubMed ID: 66957
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.
Schein PS; DeVita VT; Hubbard S; Chabner BA; Canellos GP; Berard C; Young RC
Ann Intern Med; 1976 Oct; 85(4):417-22. PubMed ID: 61732
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo).
Case DC
Oncology; 1983; 40(3):186-91. PubMed ID: 6189041
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy of advanced, diffuse, non-Hodgkin's lymphoma: results with cyclo-phosphamide, adriamycin, vincristine, prednisone, and bleomycin (CHOP-Bleo).
Case DC
J Maine Med Assoc; 1979 Sep; 70(9):348-50, 352, 368. PubMed ID: 92513
[No Abstract] [Full Text] [Related]
6. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
[TBL] [Abstract][Full Text] [Related]
7. Advances in chemotherapy for large cell lymphoma.
Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
[TBL] [Abstract][Full Text] [Related]
8. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
9. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study.
Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Butler JJ; Byrne GE; Moon TE; Fisher R; Haskins CL; Coltman CA
Cancer; 1979 Feb; 43(2):417-25. PubMed ID: 84706
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy (modified CHOP-Bleo) in non-Hodgkin's lymphoma].
Hiruma K; Asai T; Aotsuka N; Hirasawa A; Wakita H; Endoh N; Nakamura H; Oh H; Yoshida S; Igarashi T
Gan To Kagaku Ryoho; 1990 Jan; 17(1):59-64. PubMed ID: 1688699
[TBL] [Abstract][Full Text] [Related]
11. Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens.
Cabanillas F; Rodriguez V; Freireich EJ
Med Pediatr Oncol; 1978; 4(4):321-31. PubMed ID: 364284
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy.
Fisher RI; DeVita VT; Johnson BL; Simon R; Young RC
Am J Med; 1977 Aug; 63(2):177-82. PubMed ID: 70170
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
14. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).
Skarin AT; Canellos GP; Rosenthal DS; Case DC; MacIntyre JM; Pinkus GS; Moloney WC; Frei E
J Clin Oncol; 1983 Feb; 1(2):91-8. PubMed ID: 6199472
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
[TBL] [Abstract][Full Text] [Related]
16. Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
Cabanillas F; Burgess MA; Bodey GP; Freireich EJ
Am J Med; 1983 Mar; 74(3):382-8. PubMed ID: 6187213
[TBL] [Abstract][Full Text] [Related]
17. A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma.
Lee R; Cabanillas F; Bodey GP; Freireich EJ
J Clin Oncol; 1986 Oct; 4(10):1455-61. PubMed ID: 2428947
[TBL] [Abstract][Full Text] [Related]
18. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
Bonadonna G; Monfardini S; Villa E
Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
[TBL] [Abstract][Full Text] [Related]
19. Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma.
Avilés A; Neri N; Castañeda C; Talavera A; Huerta-Guzmán J; González M
Med Oncol; 2002; 19(1):55-8. PubMed ID: 12025891
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
